Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval No new update. New Formulation Approval No new update. New Indication Approval Botox® (onabotulinumtoxinA) – New Expanded Indication Approval – July 9, 2020 – Allergan, an AbbVie company,… Read more »
-
-
RxStrategies, Proud Pinnacle Partner of the 340B Coalition Virtual Summer Conference
We are looking forward to the 340B Coalition Virtual Summer Conference, taking place online, on July 20 – 29. RxStrategies is a proud Pinnacle Partner of the event and Premier Level Charity Sponsor. Our team members Jonathan Ghenn, Todd Hudnall, Krista Scanlon and Rhodie Smith will be attending the event and will be meeting… Read more »
-
Clinical Insights: July 14, 2020
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval UpneeqTM (oxymetazoline hydrochloride) Ophthalmic Solution – New Drug Approval – July 8, 2020 – Osmotica Pharmaceuticals plc, a fully integrated biopharmaceutical company, announced that the U.S. Food and… Read more »
-
Clinical Insights: July 7, 2020
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval ByfavoTM (remimazolam) Injection – New Drug Approval – July 2, 2020 – Cosmo Pharmaceuticals announced that the US Food and Drug Administration (FDA) has approved Byfavo™ (remimazolam injection)… Read more »
-
Clinical Insights: June 30, 2020
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval Fintepla® (fenfluramine) Oral Solution – New Drug Approval – June 26, 2020 – The U.S. Food and Drug Administration approved Fintepla® (fenfluramine), a Schedule IV controlled substance, for… Read more »
-
Clinical Insights: June 23, 2020
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval GimotiTM (metoclopramide) Nasal Spray – New Drug Approval – June 19, 2020 – Evoke Pharma, Inc., a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, announced… Read more »
-
Clinical Insights: June 16, 2020
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval ZepzelcaTM (lurbinectedin) Injection – New Drug Approval – June 15, 2020 – PharmaMar announced, along with Jazz Pharmaceuticals plc, that the U.S. Food and Drug Administration (FDA) has… Read more »
-
Clinical Insights: June 9, 2020
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval No new update. New Formulation Approval No new update. New Indication Approval RecarbrioTM (imipenem-cilastatin and relebactam) Injection – New Drug Indication Approval – June 4, 2020 –… Read more »
-
Clinical Insights: June 2, 2020
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval OriahnnTM (elagolix/estradiol/norethindrone acetate and elagolix) Capsules – New Drug Approval – May 29, 2020 – The U.S. Food and Drug Administration granted approval to OriahnnTM (an estrogen and… Read more »
-
Clinical Insights: May 27, 2020
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval PhexxiTM (lactic acid, citric acid and potassium bitartrate) Vaginal Gel – New Drug Approval – May 22, 2020 – Evofem Biosciences, Inc. announced that the U.S. Food… Read more »